416 reports of this reaction
2.2% of all MISOPROSTOL reports
#10 most reported adverse reaction
VOMITING is the #10 most commonly reported adverse reaction for MISOPROSTOL, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 416 FDA adverse event reports linking MISOPROSTOL to VOMITING. This represents approximately 2.2% of all 18,857 adverse event reports for this drug.
Patients taking MISOPROSTOL who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VOMITING is a less commonly reported adverse event for MISOPROSTOL, but still significant enough to appear in the safety profile.
In addition to vomiting, the following adverse reactions have been reported for MISOPROSTOL:
The following drugs have also been linked to vomiting in FDA adverse event reports:
VOMITING has been reported as an adverse event in 416 FDA reports for MISOPROSTOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
VOMITING accounts for approximately 2.2% of all adverse event reports for MISOPROSTOL, making it a notable side effect.
If you experience vomiting while taking MISOPROSTOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.